• S&P Futures

    4,010.25
    +7.00 (+0.17%)
     
  • Dow Futures

    34,052.00
    +66.00 (+0.19%)
     
  • Nasdaq Futures

    11,820.50
    +14.75 (+0.12%)
     
  • Russell 2000 Futures

    1,845.20
    +3.30 (+0.18%)
     
  • Crude Oil

    77.58
    +0.65 (+0.84%)
     
  • Gold

    1,786.60
    +5.30 (+0.30%)
     
  • Silver

    22.62
    +0.20 (+0.91%)
     
  • EUR/USD

    1.0508
    +0.0010 (+0.09%)
     
  • 10-Yr Bond

    3.5990
    +0.0930 (+2.65%)
     
  • Vix

    20.75
    +1.69 (+8.87%)
     
  • GBP/USD

    1.2206
    +0.0012 (+0.10%)
     
  • USD/JPY

    136.8090
    +0.1240 (+0.09%)
     
  • BTC-USD

    17,053.13
    -173.81 (-1.01%)
     
  • CMC Crypto 200

    403.20
    -8.01 (-1.95%)
     
  • FTSE 100

    7,567.54
    +11.31 (+0.15%)
     
  • Nikkei 225

    27,902.11
    +81.71 (+0.29%)
     

Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?

Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?

This drugmaker has earned two new drug approvals in as many months, but its success isn't reflected in its market valuation yet.